Cynomolgus CD117 / c-kit Protein, His Tag (MALS verified)
分子別名(Synonym)
CD117,SCFR,c-Kit,KIT
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Cynomolgus CD117, His Tag (CD7-C52H9) is expressed from human 293 cells (HEK293). It contains AA Gln 26 - Thr 521 (Accession # XP_005555329.1).
Predicted N-terminus: Gln 26
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 57.6 kDa. The protein migrates as 70-90 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
>90% as determined by SEC-MALS.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
Mast/干細(xì)胞生長因子受體試劑盒(c-Kit)是蛋白激酶超家族、Tyr蛋白激酶家族和CSF-1/PDF受體亞家族的成員,也被稱為花斑性狀蛋白(PBT)、p145 c-Kit、酪氨酸蛋白激酶試劑盒和CD117,其中包含五個(gè)Ig樣C2型(免疫球蛋白樣)結(jié)構(gòu)域和一個(gè)蛋白激酶結(jié)構(gòu)域。CD117作為細(xì)胞因子KITLG/SCF的細(xì)胞表面受體,在調(diào)節(jié)細(xì)胞存活和增殖、造血、干細(xì)胞維持、配子發(fā)生、肥大細(xì)胞發(fā)育、遷移和功能以及黑色素生成中起著至關(guān)重要的作用。作為對KITLG/SCF結(jié)合的反應(yīng),CD117可以激活多種信號通路。此外,活化的KIT促進(jìn)蛋白磷酸酶PTPN6/SHP-1和PTPRU以及轉(zhuǎn)錄因子STAT1、STAT3、STAT5A和STAT5B的磷酸化。
關(guān)鍵字: CD117;CD117蛋白;CD117重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。